Literature DB >> 34934452

GATA4 regulates osteogenic differentiation by targeting miR-144-3p.

Tao Qiu1,2,3, Haotian Li1,2,3, Tao Lu2,3, Liping Shu2,3, Chao Chen1,2,3, Chunqing Wang1.   

Abstract

Numerous studies have demonstrated that microRNAs (miRNAs or miRs) play an important role in regulating osteogenic differentiation, but their specific regulatory mechanism requires further investigation. In the present study, it was revealed that during osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMSCs), the expression level of miR-144-3p was decreased with increased osteogenic induction duration and was negatively associated with osteogenic marker gene expression. Overexpression of miR-144-3p inhibited osteogenic differentiation, while inhibition of miR-144-3p expression promoted osteogenic differentiation. In addition, dual-luciferase activity analysis and adenovirus infection experiments revealed that GATA binding protein 4 targeted miR-144-3p for regulation and that overexpression of GATA4 promoted the expression of miR-144-3p. These data indicated that miR-144-3p plays a role in inhibiting BMSC osteogenic differentiation and that GATA4 inhibits osteogenic differentiation by targeting miR-144-3p expression.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  GATA binding protein 4; bone marrow mesenchymal stem cells; microRNA-144-3p; osteogenic differentiation

Year:  2021        PMID: 34934452      PMCID: PMC8652393          DOI: 10.3892/etm.2021.11006

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  38 in total

1.  Isolation of rat bone marrow stem cells.

Authors:  Sarah Snykers; Tamara Vanhaecke; Vera Rogiers
Journal:  Methods Mol Biol       Date:  2006

Review 2.  A look behind the scenes: the risk and pathogenesis of primary osteoporosis.

Authors:  Gretl Hendrickx; Eveline Boudin; Wim Van Hul
Journal:  Nat Rev Rheumatol       Date:  2015-04-21       Impact factor: 20.543

3.  Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture.

Authors:  Layla Panach; Damián Mifsut; Juan J Tarín; Antonio Cano; Miguel Ángel García-Pérez
Journal:  Calcif Tissue Int       Date:  2015-07-11       Impact factor: 4.333

4.  TIEG1 Inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4.

Authors:  Qin Li; Peiye Shen; Siyu Zeng; Peiqing Liu
Journal:  J Cardiovasc Pharmacol       Date:  2015-08       Impact factor: 3.105

Review 5.  MicroRNA functions in osteogenesis and dysfunctions in osteoporosis.

Authors:  Andre J van Wijnen; Jeroen van de Peppel; Johannes P van Leeuwen; Jane B Lian; Gary S Stein; Jennifer J Westendorf; Merry-Jo Oursler; Hee-Jeong Im; Hanna Taipaleenmäki; Eric Hesse; Scott Riester; Sanjeev Kakar
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

6.  miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation.

Authors:  J Kureel; M Dixit; A M Tyagi; M N Mansoori; K Srivastava; A Raghuvanshi; R Maurya; R Trivedi; A Goel; D Singh
Journal:  Cell Death Dis       Date:  2014-02-06       Impact factor: 8.469

7.  Identification of suitable reference gene and biomarkers of serum miRNAs for osteoporosis.

Authors:  Jian Chen; Kai Li; Qianqian Pang; Chao Yang; Hongyu Zhang; Feng Wu; Hongqing Cao; Hongju Liu; Yumin Wan; Weibo Xia; Jinfu Wang; Zhongquan Dai; Yinghui Li
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

8.  miR-628-3p regulates osteoblast differentiation by targeting RUNX2: Possible role in atrophic non-union.

Authors:  Hua Chen; Xinran Ji; Fei She; Yuan Gao; Peifu Tang
Journal:  Int J Mol Med       Date:  2016-12-28       Impact factor: 4.101

9.  Downregulation of LINC00707 promotes osteogenic differentiation of human bone marrow‑derived mesenchymal stem cells by regulating DKK1 via targeting miR‑103a‑3p.

Authors:  Jun Liu; Minfei Wu; Guang Feng; Rui Li; Yang Wang; Jianhang Jiao
Journal:  Int J Mol Med       Date:  2020-07-09       Impact factor: 4.101

Review 10.  MicroRNA function and dysregulation in bone tumors: the evidence to date.

Authors:  Mary Nugent
Journal:  Cancer Manag Res       Date:  2014-01-07       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.